Position in TEVA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$901,987
-$16,492 QoQ
Shares Held
26,623
-12.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#347
of 671 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VestGen Advisors, LLC holds $14,196,270 across 7 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
707,099 | $11,228,732 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
26,623 | $901,987 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
34,961 | $860,390 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
872 | $472,475 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,368 | $399,102 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
5,774 | $200,184 | |
| 7 | HLN |
Haleon plc
|
14,298 | $133,400 |
All Filings in TEVA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $901,987 | 26,623 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $918,479 | 30,494 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $637,682 | 20,432 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $357,843 | 17,715 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||